m6 一个修改:抗癌疗法的新途径
Yongtai Bai1, Kai Li1,2,3, Jinying Peng1
1State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing 100871, China.
Life medicine
|January 28, 2025
概括
本综述详细介绍了N-6-甲基氨酸 (m6A) RNA的修饰,这对于基因表达至关重要,并且与癌症有关. 它探索了m6A.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 存在超过170种RNA化学修饰,影响RNA处理,出口,翻译和衰变.
- N-6-甲基氨酸 (m6A) 是一个关键的内部RNA修饰,主要由METTL3-METTL14-WTAP复合体调节.
- 异常的m6A修饰越来越多地与癌症的发生,发展,进展和预后有关.
研究的目的:
- 审查最近在m6A修饰方面的发现.
- 阐明m6A在癌症发展和进展中的关键作用.
- 总结m6A在癌症中的机制,并确定潜在的治疗点.
主要方法:
- 关于m6A修饰的最近研究的文献综述.
- 对m6A在各种癌症类型中的参与进行分析.
- 识别m6A调节器 (写字器,擦拭器) 作为潜在的治疗点.
主要成果:
- 在多个癌症阶段,m6A修饰起着重要的作用.
- 调节m6A调节者的失调会影响癌症的进展.
- 针对m6A编写器 (例如,METTL3) 和擦拭器 (例如,FTO) 显示了治疗潜力.
结论:
- m6A修饰是癌症生物学中的一个关键因素.
- 了解m6A通路为癌症治疗提供了新的途径.
- 准m6A调节器是癌症治疗的一个有希望的策略.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K


